Medical Journals

An Elisa Method for the Detection and Quantification of Human Heparanase.

Authors:
  • Shafat Itay
  • Zcharia Eyal
  • Nisman Benjamin
  • Nadir Yona
  • Nakhoul Farid
  • Vlodavsky Israel
  • Ilan Neta

From: Cancer and Vascular Biology Research Center, The Bruce Rappaport Faculty of Medicine, Technion, Haifa 31096, Israel.

Biochemical and biophysical research communications

  • Publish Date: Mar 2006
  • ISSN: 0006-291X
  • Volume: 341
  • Issue: 4
  • Pages: 958-63
  • Medium: Print
  • Language: English
  • Citation (JAMA): Shafat Itay, Zcharia Eyal, Nisman Benjamin, et al. An Elisa Method for the Detection and Quantification of Human Heparanase.. Biochem. Biophys. Res. Commun. Mar 2006;341:958-63

Abstract

Heparanase is a mammalian endo-beta-D-glucuronidase that cleaves heparan sulfate side chains at a limited number of sites. Heparanase enzymatic activity is thought to participate in degradation and remodeling of the extracellular matrix and to facilitate cell invasion associated with tumor metastasis, angiogenesis, and inflammation. Traditionally, heparanase activity was well correlated with the metastatic potential of a large number of tumor-derived cell types. More recently, heparanase upregulation was detected in an increasing number of primary human tumors, correlating, in some cases, with poor postoperative survival and increased tumor vascularity. The present study was undertaken to develop a highly sensitive ELISA suitable for the determination and quantification of human heparanase in tissue extracts and body fluids. The assay preferentially detects the 8+50 kDa active heparanase heterodimer vs. the latent 65 kDa proenzyme and correlates with immunoblot analysis of heparanase containing samples. It detects heparanase at concentrations as low as 200 pg/ml and is suitable for quantification of heparanase in tissue extracts and urine.

Mesh Headings (Keywords): Animals, Biological Markers, Carcinoma, Transitional Cell, Diabetic Nephropathies, Enzyme-Linked Immunosorbent Assay, Glucuronidase, Humans, Leukemia, Liver, Lung, Mice, Urinary Bladder Neoplasms


Check for Full Text / PubMed Unique Identifier (PMID): 16458254


This abstract is part of PubMed, a service of the U.S. National Library of Medicine. PubMed includes more than 17 million citations from MEDLINE and other life science journals for biomedical articles. See Copyright and Disclaimers.

Linked medical terms appearing on this page are added by Healia to help readers find more information and are not part of the original PubMed document.

The data herein was last updated on July 8th, 2008 and may not reflect the most current and accurate data available from NLM.


Advertisements

About | Privacy Policy | Business Solutions | Advertise | Contact | Add Healia to your site

©2012. Healia / Meredith Corporation  

Use of this site constitutes acceptance of our Terms of Service and Privacy Policy. All content on this Web site, including medical opinion and any other health-related information, is for informational purposes only and should not be used for a specific diagnosis or individual treatment plan for any situation. Use of this site and the information contained herein does not create a doctor-patient relationship. Always seek the direct advice of your doctor in connection with any questions or issues you may have regarding your own health or the health of others.